GMJ Briefs
What This Anxiety Breakthrough Means for Future Treatment Development
Three key findings from anxiety circuit research point toward more precise, targeted treatments with fewer side effects.
Experimental Compound Slows Nerve Cell Loss in Alzheimer’s Preclinical Studies
An experimental compound reduced nerve cell loss in Alzheimer's mouse models by targeting a newly identified cellular mechanism distinct from…
Scientists Crack the Code on Protein Shake Palatability
New manufacturing process eliminates bitter taste in protein supplements while maintaining nutritional integrity and texture quality.
Three Critical Lessons From Maternal Healthcare Study: Moving Beyond Coverage Metrics
New study shows exemplar countries need quality metrics beyond coverage statistics to truly advance maternal healthcare.
Single Brazilian Introduction Seeded Cuba’s 2024 Oropouche Outbreak, Genome Analysis Reveals
Phylogenetic analysis of whole genomes from Cuba's 2024 Oropouche outbreak identifies a single introduction from Brazil in early 2024, according…
🚨 Ebola continues to spread in DRC as death toll passes 500, WHO warns
The outbreak of the deadly Bundibugyo species of Ebola in the eastern Democratic Republic of the Congo (DRC) is expanding,…
Swallowable Capsule Technology Offers Continuous Core Temperature Monitoring
A blueberry-sized ingestible capsule offers continuous core temperature monitoring, addressing limitations of traditional thermometers in detecting fever.
Critical Vaccine Gap: 300,000 Annual Lassa Cases Lack Licensed Prevention Options
Zero licensed Lassa fever vaccines exist despite affecting hundreds of thousands annually in West Africa.